Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea · Delayed Price · Currency is KRW
7,280.00
-250.00 (-3.32%)
At close: Apr 8, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 129.49B | 196.93B | 182.49B | 169.66B | - | | | |
| | | -34.25% | 7.91% | 7.56% | - | - | | | |
Consolidation Adjustments | | | -3.56B | -6.02B | - | - | - | | | |
Drug Manufacturing and Sales | | | - | - | - | - | 168.19B | | | |
Drug Manufacturing and Sales Growth | | | - | - | - | - | -13.40% | | | |
| | | 125.93B | 190.91B | 182.49B | 169.66B | 168.19B | | | |
| | | -34.04% | 4.61% | 7.56% | 0.87% | -13.40% | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 125.78B | 190.71B | 182.43B | 169.48B | 168.11B | | | |
| | | -34.05% | 4.54% | 7.64% | 0.81% | -13.37% | | | |
| | | 149.84M | 202.44M | 61.00M | 183.15M | 84.12M | | | |
| | | -25.99% | 231.89% | -66.70% | 117.74% | -46.77% | | | |
| | | 125.93B | 190.91B | 182.49B | 169.66B | 168.19B | | | |
| | | -34.04% | 4.61% | 7.56% | 0.87% | -13.40% | | | |
Source: S&P Global Market Intelligence.
